We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Rockwell Automation
ROK
$48.1B
| $1.26M | 0.03% |
12,405
-310
| -2% | -$35.1K |
|
252
Insulet
PODD
$9.95B
| $1.23M | 0.02% |
47,282
-3,904
| -8% | -$118K |
|
|
EFOR
253
Everforth Inc
EFOR
$1.3B
| $1.21M | 0.02% |
32,908
+13,167
| +67% | +$500K |
|
|
CARB
254
DELISTED
Carbonite Inc
CARB
| $1.19M | 0.02% |
107,163
+38,820
| +57% | +$446K |
|
|
HCC
255
DELISTED
HCC INSURANCES HOLDINGS INC
HCC
| $1.17M | 0.02% |
15,061
| – | – |
|
|
MHNB.CL
256
DELISTED
Maiden Holdings North America
MHNB.CL
| $1.13M | 0.02% |
42,800
+700
| +2% | +$18.6K |
|
257
Trex
TREX
$4.69B
| $1.13M | 0.02% |
134,964
+50,888
| +61% | +$523K |
|
258
Jefferies Financial Group
JEF
$12.2B
| $1.12M | 0.02% |
61,900
-36
| -0.1% | -$723 |
|
|
ELLI
259
DELISTED
Ellie Mae Inc
ELLI
| $1.11M | 0.02% |
+16,647
| New | +$1.23M |
|
260
Colgate-Palmolive
CL
$72.5B
| $1.1M | 0.02% |
17,290
-28
| -0.2% | -$1.83K |
|
261
WisdomTree
WT
$3.79B
| $1.09M | 0.02% |
67,632
+24,645
| +57% | +$519K |
|
262
Diamondback Energy
FANG
$56.1B
| $1.08M | 0.02% |
16,660
+4,690
| +39% | +$319K |
|
263
Sabre
SABR
$864M
| $1.05M | 0.02% |
38,691
-704
| -2% | -$19K |
|
264
Norfolk Southern
NSC
$78.1B
| $1.04M | 0.02% |
13,651
+9
| +0.1% | +$731 |
|
265
UnitedHealth
UNH
$355B
| $1.04M | 0.02% |
8,980
+138
| +2% | +$16.5K |
|
266
Amgen
AMGN
$236B
| $1.04M | 0.02% |
7,511
+608
| +9% | +$95.8K |
|
267
Oxford Square Capital
OXSQ
$146M
| $1.04M | 0.02% |
154,723
| – | – |
|
|
KMPA
268
DELISTED
Kemper Corporation
KMPA
| $1.04M | 0.02% |
39,300
+600
| +2% | +$15.9K |
|
269
Leggett & Platt
LEG
$1.26B
| $1.03M | 0.02% |
25,051
+1,170
| +5% | +$54.6K |
|
270
US Bancorp
USB
$97.2B
| $1.02M | 0.02% |
24,964
-3,738
| -13% | -$162K |
|
271
Bank of America
BAC
$428B
| $1.02M | 0.02% |
65,491
+19,795
| +43% | +$333K |
|
272
Lazard
LAZ
$4.21B
| $1.01M | 0.02% |
23,230
| – | – |
|
|
SBY
273
DELISTED
Silver Bay Realty Trust Corp.
SBY
| $990K | 0.02% |
61,817
-9,999
| -14% | -$163K |
|
|
VNRBP
274
DELISTED
Vanguard Natural Resources LLC 7.625% Series B Cumulative Redeemable Perpetual Preferred Unit
VNRBP
| $931K | 0.02% |
61,190
+550
| +0.9% | +$10.2K |
|
|
TW
275
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $926K | 0.02% |
7,887
-6,940
| -47% | -$859K |
|
Similar funds
CAM
VKH
DL
RBC
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.